Skip to Content
Skip to Content

Оценка на веществата - CoRAP

Оценка на веществата - CoRAP

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 13 Декември 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Information requested
Details
622-542-2
3891-98-3
2020
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Not started
Details
203-680-9
109-55-7
2014
Austria
Sensitiser
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
202-525-2
96-69-5
2015
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Information requested
Details
204-820-1
127-06-0
2016
Austria
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of environment
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
201-247-9
80-07-9
2019
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
212-791-1
870-08-6
2021
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
249-535-3
29253-36-9
2020
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
203-571-6
108-31-6
2013
Austria
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
221-374-3
3081-01-4
2012
Austria
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
231-890-0
7775-14-6
2016
Austria
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
222-020-0
3319-31-1
2012
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
206-022-9
288-88-0
2015
Belgium
Suspected CMR
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
216-475-4
1594-08-7
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
211-989-5
732-26-3
2017
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
226-866-1
5521-31-3
2021
Belgium
Suspected PBT/vPvB
Not started
Details
203-079-1
103-09-3
2015
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Concluded
Details
432-520-2
232938-43-1
2020
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Not started
Details
215-925-7
1453-58-3
2018
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Ongoing
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
405-520-5
95235-30-6
2021
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
700-403-8
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Ongoing
Details
-
-
2018
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
253-775-4
38083-17-9
2014
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Information requested
Details
203-629-0
108-91-8
2016
Belgium
Reprotoxic
Exposure of environment
High (aggregated) tonnage
Concluded
Details
214-189-4
1112-39-6
2020
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Not started
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
221-375-9
3081-14-9
2012
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
267-636-0
67905-17-3
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Not started
Details
201-344-6
81-33-4
2021
Belgium
Suspected PBT/vPvB
Not started
Details
202-307-7
94-13-3
2015
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Wide dispersive use
Information requested
Details
473-390-7
-
2016
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
907-745-9
-
2015
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Follow-up
Details
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Follow-up
Details
202-773-1
99-62-7
2020
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
202-826-9
100-18-5
2020
Bulgaria
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
203-820-9
110-97-4
2013
Czech Republic
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
219-470-5
2440-22-4
2016
Czech Republic
Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
202-804-9
99-96-7
2014
Czech Republic
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Concluded
Details
217-175-6
1762-95-4
2015
Czech Republic
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Conclusion under preparation
Details
271-082-5
68515-40-2
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Information requested
Details
700-989-5
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Ongoing
Details
271-089-3
68515-47-9
2014
Denmark
High (aggregated) tonnage
Other exposure/risk based concern
Suspected CMR
Ongoing
Details
271-085-1
68515-43-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Ongoing
Details
216-823-5
1675-54-3
2015
Denmark
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
253-057-0
36483-57-5
2021
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Not started
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
218-645-3
2210-79-9
2016
Denmark
Mutagenic
Information requested
Details
202-627-7
98-01-1
2021
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
249-204-3
28768-32-3
2013
Denmark
CMR
Wide dispersive use
Information requested
Details
1 - 4.5 moles propoxylated
500-097-4
37353-75-6
2013
Denmark
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
204-327-1
119-47-1
2016
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
204-337-6
119-61-9
2013
Denmark
Suspected CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
270-877-4
68479-98-1
2016
Denmark
Suspected Mutagenic
Suspected Reprotoxic
Ongoing
Details
287-401-6
85507-79-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Ongoing
Details
500-006-8
9003-36-5
2020
Denmark
Potential endocrine disruptor
Not started
Details
700-960-7
-
2012
Denmark
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
205-031-5
131-57-7
2014
Denmark
Potential endocrine disruptor
Cumulative exposure
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
225-716-2
5026-74-4
2021
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Not started
Details
203-632-7
108-95-2
2015
Denmark
Suspected Mutagenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
911-815-4
-
2020
Denmark
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Cumulative exposure
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
205-288-3
137-30-4
2012
Denmark
Potential endocrine disruptor
High RCR
Information requested
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Not started
Details
701-276-1
-
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Not started
Details
202-966-0
101-68-8
2013
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Concluded
Details
905-806-4
-
2015
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Ongoing
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Not started
Details
203-090-1
103-23-1
2020
Finland
Suspected CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Not started
Details
202-046-9
91-17-8
2012
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
206-354-4
330-54-1
2014
Finland
Potential endocrine disruptor
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
203-624-3
108-87-2
2013
Finland
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
266-042-9
65997-13-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
264-848-5
64365-17-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
203-585-2
108-46-3
2016
Finland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-625-9
108-88-3
2012
Finland
CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-002-1
102-06-7
2012
France
CMR
High (aggregated) tonnage
High RCR
Ongoing
Details
204-077-3
115-27-5
2013
France
CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
Exposure of workers
Information requested
Details
204-881-4
128-37-0
2016
France
Potential endocrine disruptor
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2021
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
239-701-3
15625-89-5
2014
France
Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
212-782-2
868-77-9
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
202-112-7
91-97-4
2013
France
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Concluded
Details
201-126-0
78-59-1
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Ongoing
Details
201-618-5
85-60-9
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
247-118-0
25584-83-2
2021
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
231-208-1
7446-70-0
2015
France
Suspected CMR
Exposure of workers
High (aggregated) tonnage
High RCR
Information requested
Details
215-477-2
1327-41-9
2015
France
Suspected CMR
High (aggregated) tonnage
Information requested
Details

Export search results to:

Categories Display

Маркирано като:

(за търсене на свързано съдържание кликнете върху тага)


Route: .live2